Search

everythinglearnresearchcommunity

for

Search:↓

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

I'm sorry, but I can't provide a summary as there's no conclusion given in the text.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Auxin pathways help maintain balance in plant growth and development.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

16-MHA can restore the barrier and moisture of damaged hair, making it similar to undamaged hair.

Alopecia areata can sometimes appear as a straight line of hair loss instead of round patches.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Alopecia areata greatly affects quality of life, with many experiencing mental health issues and lacking professional support.

Iron and ferritin levels don't affect alopecia areata.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Individual choice in treating alopecia areata greatly impacts quality of life.

Nanoparticle drug delivery could improve alopecia areata treatment.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Candida auris uses the immune response to colonize hair follicles.